Essilor to present new clinical results in myopia progression slow-down

After two years of clinical trials on 167 myopic children in collaboration with the Wenzhou Medical University in China, Essilor will present next month new results for its Essilor Stellest lens’ performance in the reduction of myopia progression among children. According to preliminary information communicated by the French lens maker, ...

Keep reading this article by becoming a member


Enjoy unrestricted access to Eyewear Intelligence

To continue reading this article subscribe now

  • Unlimited access to our highly trusted industry insights and analysis
  • Benchmark yourself against the market and competitors
  • Find inspiration to drive your business forward
  • Stay up to date with new business models and startups

If you aren’t ready to subscribe now, you can REGISTER FOR FREE. Already an Eyewear Intelligence subscriber? Sign in here.